TURNER BRIAN V
Known title: DirectorCIK: 0001229279
Associated companies
Transaction History
| MVIS | ▲ Buy | Option Exercise | 20,113 | $0 | 9/3/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 5/17/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 3/1/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 12/1/2023 | View on chart |
| MVIS | ▲ Buy | Grant | 5,076 | $10K | 11/13/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 9/1/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 5/16/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 3/1/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 12/1/2022 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 9/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
MicroVision stock falls after reaffirming 2026 revenue outlook
MicroVision shares declined after the company reaffirmed its 2026 revenue outlook and outlined its path to profitability. Despite these updates on commercial growth, the stock dropped in trading. The share price is currently near its 52-week low, reflecting the market's reaction to the reiterated guidance.
MicroVision stock falls after reaffirming 2026 revenue outlook. MicroVision shares declined after the company reaffirmed its 2026 revenue outlook and outlined its path to profitability. Despite these updates on commercial growth, the stock dropped in trading. The share price is currently near its 52-week low, reflecting the market's reaction to the reiterated guidance.